You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | n/a |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -2.5 | n/a |
| PEG | 0.0 | n/a |
| Price / Revenue | 0.0 | n/a |
| Price / Book value | 4.2 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | 0.08 | -7.96 | -5.19p | -2.3 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 0.08 | -6.74 | -3.99p | -4.0 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | 0.13 | -7.25 | 3.43p | 3.9 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | 0.12 | -8.94 | -3.25p | -2.0 | 0.0 | n/a | n/a | 0.0% |
| 2022-12-31 | n/a | -4.46 | -1.26p | -1.5 | 0.0 | n/a | n/a | 0.0% |
| ImmuPharma progresses P140 clinical programme with FDA Sharecast News | 12 Apr |
|---|---|
| ImmuPharma upbeat after meeting with US partner Avion Sharecast News | 11 Nov |
| ImmuPharma's US partner receives FDA response on Lupuzor Sharecast News | 14 Sep |
| IMM RNS Posting of RA and Notice of AGM 30 June 23 | 06-Jun-23 14:28 |
|---|---|
| Positive Pre-IND meeting with FDA | 18-May-23 14:36 |
| Final Results | 11-May-23 14:46 |
| Holding(s) in Company | 10-May-23 23:02 |
| Lupozor Update - FDA confirms Type-C meeting date | 19-Apr-23 14:43 |